Ergoteles LLC Vertex Pharmaceuticals Inc Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $997,536 - $1.14 Million	3,522 Added 53.18%	10,145 $3.2 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.89 Million - $2.13 Million	6,623 New	6,623 $1.91 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $7.48 Million - $8.37 Million	-41,211 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $7.73 Million - $9.11 Million	41,211 New	41,211 $8.31 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $820,006 - $955,828	-3,961 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $819,966 - $1.09 Million	3,961 New	3,961 $936,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.